Morton Brown Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Buy
224
+24
+12% +$1.38K ﹤0.01% 188
2026
Q1
$12.1K Hold
200
﹤0.01% 182
2025
Q4
$10.8K Hold
200
﹤0.01% 188
2025
Q3
$9.02K Hold
200
﹤0.01% 192
2025
Q2
$9.26K Hold
200
﹤0.01% 197
2025
Q1
$12.2K Hold
200
﹤0.01% 179
2024
Q4
$11.3K Buy
200
+25
+14% +$1.4K ﹤0.01% 168
2024
Q3
$9.05K Buy
175
+75
+75% +$3.52K ﹤0.01% 173
2024
Q2
$4.24K Buy
+100
New +$4.47K ﹤0.01% 177
2022
Q4
Sell
-47
Closed -$3K 169
2022
Q3
$3K Hold
47
﹤0.01% 156
2022
Q2
$4K Buy
+47
New +$3.58K ﹤0.01% 155

Other funds holding BMY

Morton Brown Family Wealth's BMY Position: Q2 2026 in Review

Morton Brown Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $1.38K and bringing the position to 224 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #188.

Morton Brown Family Wealth first reported a position in BMY in Q2 2022 and has held it in 11 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Morton Brown Family Wealth held 224 shares of Bristol-Myers Squibb worth $12.9K as of Q2 2026.
  • Morton Brown Family Wealth bought 24 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.38K.
  • Bristol-Myers Squibb made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #188 holding.
  • Morton Brown Family Wealth first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 11 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.